PATENT CLAIM ANALYSIS

Application Number: 16216420
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "318000"]

Abstract:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Claim (Index 2):
A compound according to Formula (Ia) or a pharmaceutically acceptable salt thereof, wherein X is N or CH; Y is N; A is CH 2 ; R is hydrogen, C 1 -C 4 alkyl or trifluoromethyl; R 1  is hydrogen, halogen or C 1 -C 4 alkyl; R 2  is piperidinyl which is N-substituted with C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, haloC 1 -C 4 alkyl, C(O)C 1 -C 4 alkyl, C(O)C 3 -C 6 cycloalkyl, C(O)haloC 1 -C 4 alkyl or C(O)C 1 -C 4 alkoxy; R 3  is hydrogen or C 1 -C 4 alkyl; or R 2  and R 3 , taken in combination, form a 5 or 6 member fused saturated azacyclic ring optionally substituted with benzyl or 5 or 6 member heteroarylmethyl, which heteroaryl has 1 or 2 ring heteroatoms independently selected from N, O and S; R 4  is hydrogen or C 1 -C 4 alkyl and R 5  is hydrogen, halogen, C 1 -C 4 alkyl or C 3 -C 6 cycloalkyl.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15320810', '15320813', '15320815', '16063059', '15911797']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8327526457557011
- 35 USC 102 Novelty (BERT): 0.5642677841680983
- Combined Prediction Score: 0.8059041595969408
- Mean Citation Score: 389.451514
- Max Citation Score: 427.36118
- Similarity Product: 418.68876617510665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test